Skip to content

Awridian Ltd

A Drug Discovery Consultancy

  • Home
  • Services
  • Resources
  • Goals
  • Publications
  • About
  • Compound Library
Posted on 24/02/202213/07/2022 by admin

EXPERIMENTAL AND IN SILICO APPROACHES TO TARGET SELECTION AND TRACTABILITY FOR DRUG DISCOVERY

The CEO of Awridian will be attended this SMR meeting on Monday 21st March 2022 at the Francis Crick Institute in London UK .

Post navigation

Previous PostPrevious Natural Product Database
Next PostNext 33rd Medicinal Chemistry in Eastern England

Recent Posts

  • Protein-Protein Interactions (PPI) 2026
  • RECENT TRENDS IN MEDICINAL CHEMISTRY AND ENABLING TECHNOLOGIES – SMR/BMCS joint meeting
  • 37th BMCS Spring Symposium on Medicinal Chemistry
  • SMR: TARGET IDENTIFICATION AND VALIDATION IN DRUG DISCOVERY
  • March 2025

Recent Comments

    Archives

    • November 2026
    • October 2026
    • February 2026
    • October 2025
    • March 2025
    • October 2024
    • March 2024
    • October 2023
    • October 2022
    • July 2022
    • February 2022
    • February 2021
    • January 2021
    • February 2020
    • January 2020
    • October 2019
    • August 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019

    Categories

    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Search Awridian

    News

    • Protein-Protein Interactions (PPI) 2026 09/11/2026
    • RECENT TRENDS IN MEDICINAL CHEMISTRY AND ENABLING TECHNOLOGIES – SMR/BMCS joint meeting 08/10/2026
    • 37th BMCS Spring Symposium on Medicinal Chemistry 26/02/2026
    • SMR: TARGET IDENTIFICATION AND VALIDATION IN DRUG DISCOVERY 19/10/2025
    • March 2025 17/03/2025
    Privacy Policy and Cookies Proudly powered by WordPress